| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2022 | Dos Santos JC, Schäfer M, Bauder-Wüst U, Beijer B, Eder M, Leotta K, Kleist C, Meyer JP, Dilling TR, Lewis JS, Kratochwil C, Kopka K, Haberkorn U, Mier W. Refined Chelator Spacer Moieties Ameliorate the Pharmacokinetics of PSMA-617. Frontiers in Chemistry. 10: 898692. PMID 36017165 DOI: 10.3389/fchem.2022.898692 | 0.412 | |||
| 2021 | Henry KE, Mack KN, Nagle VL, Cornejo M, Michel AO, Fox IL, Davydova M, Dilling TR, Pillarsetty N, Lewis JS. ERK Inhibition Improves Anti-PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. PMID 34349003 DOI: 10.1158/1535-7163.MCT-20-1112 | 0.359 | |||
| 2020 | Pandya DN, Henry KE, Day CS, Graves SA, Nagle VL, Dilling TR, Sinha A, Ehrmann BM, Bhatt NB, Menda Y, Lewis JS, Wadas TJ. Polyazamacrocycle Ligands Facilitate Zr Radiochemistry and Yield Zr Complexes with Remarkable Stability. Inorganic Chemistry. PMID 33169605 DOI: 10.1021/acs.inorgchem.0c02722 | 0.424 | |||
| 2020 | Goos JACM, Davydova M, Dilling TR, Cho A, Cornejo MA, Gupta A, Price WS, Puttick S, Whittaker MR, Quinn JF, Davis TP, Lewis JS. Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue. Nuclear Medicine and Biology. 84: 63-72. PMID 32135473 DOI: 10.1016/J.Nucmedbio.2020.02.012 | 0.46 | |||
| 2020 | Goos JACM, Cho A, Carter LM, Dilling TR, Davydova M, Mandleywala K, Puttick S, Gupta A, Price WS, Quinn JF, Whittaker MR, Lewis JS, Davis TP. Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect. Theranostics. 10: 567-584. PMID 31903138 DOI: 10.7150/Thno.36777 | 0.45 | |||
| 2019 | Henry K, Pandya D, Nikunj B, Nagle V, Dilling T, Wadas T, Lewis J. Teaching old ligands new tricks: macrocyclic chelators for zirconium-89 radiochemistry Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30229-X | 0.323 | |||
| 2018 | Henry KE, Dacek MM, Dilling TR, Caen JD, Fox IL, Evans MJ, Lewis JS. A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30228208 DOI: 10.1158/1078-0432.Ccr-18-1485 | 0.479 | |||
| 2018 | Meyer JP, Tully KM, Jackson J, Dilling TR, Reiner T, Lewis JS. Bioorthogonal masking of circulating antibody-TCO groups using tetrazine-functionalized dextran polymers. Bioconjugate Chemistry. PMID 29378403 DOI: 10.1021/Acs.Bioconjchem.8B00028 | 0.53 | |||
| 2018 | Sharma SK, Chow A, Monette S, Vivier D, Pourat J, Edwards KJ, Dilling TR, Abdel-Atti D, Zeglis BM, Poirier JT, Lewis JS. Fc-mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models. Cancer Research. PMID 29363548 DOI: 10.1158/0008-5472.Can-17-1958 | 0.462 | |||
| 2017 | Meyer JP, Kozlowski P, Jackson J, Cunanan KM, Adumeau P, Dilling TR, Zeglis BM, Lewis JS. Exploring Structural Parameters for Pretargeting Radioligand Optimization. Journal of Medicinal Chemistry. PMID 28857566 DOI: 10.1021/Acs.Jmedchem.7B01108 | 0.494 | |||
| 2017 | Henry KE, Dilling TR, Abdel-Atti D, Edwards KJ, Evans MJ, Lewis JS. Non-invasive (89)Zr-Transferrin PET Shows Improved Tumor Targeting Compared to (18)F-FDG PET in MYC-overexpressing Human Triple Negative Breast Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28848040 DOI: 10.2967/Jnumed.117.192286 | 0.487 | |||
| Show low-probability matches. | |||||